In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who come to our hospitals for treatment.” The Kolling .....
Read more

Our researchers at the Kolling Institute are working to improve the use of medications for dementia with a comprehensive analysis highlighting several concerning trends. The latest data indicates more than 420,000 people are living with dementia in Australia, including more women than men. The condition is the second leading cause of death in Australia. Leading researcher and member of the Kolling’.....
Read more

Two of the Kolling Institute’s emerging leaders are gaining attention after receiving the ATA Scientific Encouragement Award. The award, which was launched more than a decade ago, aims to provide young scientists with financial assistance to further their education and attend scientific meetings and conferences. Scientific officer Kevin Winardi from the Kolling’s Lab of Ageing and Pharmacology will.....
Read more

We would like to congratulate our early career researcher Dr Nashwa Masnoon from the Kolling’s Ageing and Pharmacology Lab who has taken out the ATA Scientific Young Scientist Encouragement Award. Nashwa, who is a postdoctoral research pharmacist, clinched the $1500 prize for her assessment of the risks and benefits of using artificial intelligence in research. The award will enable her to attend a.....
Read more

We’re kicking off the year with plenty of encouraging research news. Read on for details about new funding, fascinating research into the link between heart disease and osteoarthritis and promising work into a new diabetes treatment. We also unveil the winners of our travel awards program, generously backed by philanthropic funding. Click here: Kolling NEWS
Read more

One of our up-and-coming researchers within the Kolling’s Ageing and Pharmacology Lab has taken out two prestigious awards. Pharmacist and PhD student Mai Duong received the initial award at the International Pharmaceutical Federation World Congress in Brisbane. The APSA awarded Mai the Outstanding Oral Presentation in Pharmacy Practice prize for her discussion on the different perspectives of adve.....
Read more

Funding from the Skipper Jacobs Charitable Trust has helped a group of our young research leaders broaden their experience and establish new collaborations. Close to $40,000 was shared amongst five early-to-mid career researchers, allowing them to travel nationally and internationally to progress their research and develop new skills. One of those to receive funding is Dr Kenji Fujita, an early-car.....
Read more

A group of researchers will have the chance to broaden their skills and establish new collaborations following a funding boost from the Royal North Shore Hospital Scientific Staff Council. The council has awarded 12 travel grants to scientists working within the district and the Kolling Institute. The diverse group of leaders is driving research progress into heart and kidney disease, cancer, muscu.....
Read more

Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than a dozen researchers from the Kolling have been profiled in an international study recognising the world’s best. Published by Stanford University, the study has identified the top two per cent of researchers in the world across individual fields. The study is based on metrics from Scopus, a database o.....
Read more

A collection of emerging research leaders will have the chance to broaden their research experience thanks to funding provided through the Skipper Jacobs Charitable Trust. Close to $40,000 will be shared amongst five early-to-mid career researchers, allowing them to travel nationally and internationally expanding their research and developing new skills. It’s anticipated the travel program will not.....
Read more